This study aims to analyze the electroencephalographic power spectrum and connectivity during unresponsive states induced by propofol, esketamine and dexmedetomidine, respectively. It intends to explore the macro neural mechanisms underlying anesthetic unresponsiveness, so as to further elucidate the mechanisms by which anesthetics induce loss and recovery of consciousness. In addition, this study will identify neural biomarkers under general anesthesia for monitoring patients' actual intraoperative consciousness status. The findings will facilitate the development of monitoring indicators and devices reflecting intraoperative consciousness during general anesthesia, enabling more accurate assessment of patients' intraoperative consciousness status.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
120
All patients in this arm receive Propofol at a concentration of 10 mg/mL, administered via infusion at a dose of 1 mg/kg and completed within 5 minutes.
All subjects in this arm receive Dexmedetomidine with a prepared concentration of 10 μg/mL. A loading dose of 1.0 μg/kg is administered by infusion and completed within 10 minutes.
All subjects in this arm are given Esketamine at a prepared concentration of 5 mg/mL, infused at a dose of 0.5 mg/kg and completed within 10 minutes.
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Permutation cross mutual information (PCMI) and PCMI-based brain networks
EEG power spectrum \[broadband (0.1-45 Hz) and sub-band frequencies\] assessed by high-density EEG
Time frame: From baseline (awake) through loss of responsiveness to recovery of responsiveness
EEG functional connectivity
EEG functional connectivity assessed by high-density EEG
Time frame: From baseline (awake) through loss of responsiveness to recovery of responsiveness
heart rate
Time frame: Perioperative
Blood pressure
Time frame: Perioperative
Oxygen Saturation
Time frame: Perioperative
Time to loss of responsiveness after study drug initiation
Time frame: From start of study drug infusion until loss of responsiveness
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.